XML 18 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
OPERATING ACTIVITIES    
Net income $ 33,677 $ 211,576
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 190,603 178,327
Other Asset Impairment Charges 57,218 0
Gain on sale of real estate, net of tax (11,682) (30,490)
Loss from partnerships 6,657 1,302
Other, net 5,158 (457)
Changes in assets and liabilities, net of effects of acquisitions and dispositions:    
Increase in accounts receivable, net (11,537) (8,867)
Increase in prepaid expenses and other assets (7,672) (12,836)
Increase in accounts payable and accrued expenses 14,708 6,262
Decrease in security deposits and other liabilities (8,708) (511)
Net cash provided by operating activities 268,422 344,306
INVESTING ACTIVITIES    
Acquisition of real estate (9,589) (45,122)
Capital expenditures - development and redevelopment (302,666) (226,232)
Capital Expenditures - Other (46,530) (53,890)
Costs associated with property sold under threat of condemnation (12,924) 0
Proceeds from sale of real estate 18,096 115,781
Investment in partnerships (1,607) (980)
Distribution from partnerships in excess of earnings 849 1,798
Leasing costs (8,668) (18,751)
(Increase in) repayment of mortgage and other notes receivable, net (10,533) 130
Net cash used in investing activities (373,572) (227,266)
FINANCING ACTIVITIES    
Costs to amend revolving credit facility (638) (4,012)
Issuance of senior notes, net of costs 700,069 400,106
Issuance of notes payable, net of costs 398,742 0
Repayment of mortgages, finance leases and notes payable (4,846) (299,485)
Issuance of common shares, net of costs 170 139,729
Dividends paid to common and preferred shareholders (242,853) (232,985)
Shares withheld for employee taxes (4,035) (4,615)
Contributions from noncontrolling interests 0 272
Distributions to and redemptions of noncontrolling interests (6,634) (17,466)
Net cash provided by (used in) financing activities 839,975 (18,456)
Increase in cash, cash equivalents and restricted cash 734,825 98,584
Cash, cash equivalents, and restricted cash at beginning of year 153,614 108,332
Cash, cash equivalents, and restricted cash at end of period $ 888,439 $ 206,916